Organisation paid for research Program year 2021 Source: CMS Open Payments

Paramount Research Sols

Neither a doctor nor a teaching hospital

Research payments

$546,805

206 payments

Through program year 2021, Paramount Research Sols is reported as receiving $546,805 in research payments, across 206 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$88,413	29
2020	Research	$120,834	44
2019	Research	$337,557	133

Breakdown

Who paid Research payments · program years 2019–2021

AbbVie, Inc. $546,805 206 payments

Studies the money was for Research payments · program years 2019–2021

M16-283 $301,445 111 payments
M14-702 $95,235 52 payments
A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Combination with Estradiol/Norethindrone Acetate in Subjects with Moderate to Severe Endometriosis-Associated Pain $39,195 18 payments
A Phase 3b Study to Evaluate the Long-Term Safety of Elagolix in Combination with Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal Women $31,623 8 payments
M12-816 $31,322 6 payments
A Phase 3b Study to Evaluate the Safety and Efficacy of Elagolix in Combination with Combined Oral Contraceptives in Premenopausal Women with Documented Endometriosis and Associated Moderate to Severe Pain $17,595 3 payments
F16-974 $12,722 2 payments
M18-969 $10,750 2 payments
M12-817 $4,770 3 payments
M12-815 $2,148 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.